Ornithine carbamoyltransferase deficiency: genes and variants
Ornithine carbamoyltransferase deficiency is linked to 1 analyzed protein (OTC). 135 DNA variants are known to cause it; 141 more are uncertain, and 17 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Genes linked to Ornithine carbamoyltransferase deficiency
OTC: Ornithine transcarbamylase, mitochondrial
It combines ornithine with carbamoyl phosphate in the mitochondrial urea cycle, allowing toxic nitrogen to be converted ultimately to urea. Loss-of-function variants cause X-linked OTC deficiency and can produce life-threatening hyperammonemia.
135 disease-causing and 141 uncertain variants in OTC are linked to Ornithine carbamoyltransferase deficiency.
Known disease-causing variants in Ornithine carbamoyltransferase deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| OTC R26Q | 26 | Disease-causing (★★★★) | |
| OTC P225L | 225 | Disease-causing (★★) | |
| OTC R277Q | 277 | Disease-causing (★★) | |
| OTC R277W | 277 | Disease-causing (★★) | |
| OTC R40C | 40 | Disease-causing (★★) | |
| OTC R141Q | 141 | Disease-causing (★★) | |
| OTC P169L | 169 | Disease-causing (★★) | |
| OTC G188R | 188 | Disease-causing (★★) | |
| OTC W193R | 193 | Disease-causing (★★) | |
| OTC G195R | 195 | Disease-causing (★★) | |
| OTC D196N | 196 | Disease-causing (★★) | |
| OTC M205T | 205 | Disease-causing (★★) | |
| OTC M206K | 206 | Disease-causing (★★) | |
| OTC M206R | 206 | Disease-causing (★★) | |
| OTC P225S | 225 | Disease-causing (★★) | |
| OTC M1I | 1 | Disease-causing (★★) | |
| OTC R40H | 40 | Disease-causing (★★) | |
| OTC R129H | 129 | Disease-causing (★★) | |
| OTC M206I | 206 | Disease-causing (★★) | |
| OTC S207R | 207 | Disease-causing (★★) | |
| OTC K210E | 210 | Disease-causing (★★) | |
| OTC R40L | 40 | Disease-causing (★★) | |
| OTC K80E | 80 | Disease-causing (★★) | |
| OTC S81P | 81 | Disease-causing (★★) | |
| OTC L139S | 139 | Disease-causing (★★) | |
| OTC P158L | 158 | Disease-causing (★★) | |
| OTC I159M | 159 | Disease-causing (★★) | |
| OTC T178M | 178 | Disease-causing (★★) | |
| OTC G197R | 197 | Disease-causing (★★) | |
| OTC N199S | 199 | Disease-causing (★★) | |
| OTC A209V | 209 | Disease-causing (★★) | |
| OTC A233V | 233 | Disease-causing (★★) | |
| OTC S340F | 340 | Disease-causing (★★) | |
| OTC I53T | 53 | Disease-causing (★★) | |
| OTC R92Q | 92 | Disease-causing (★★) | |
| OTC E122G | 122 | Disease-causing (★★) | |
| OTC N161S | 161 | Disease-causing (★★) | |
| OTC Y183C | 183 | Disease-causing (★★) | |
| OTC D263G | 263 | Disease-causing (★★) | |
| OTC L304F | 304 | Disease-causing (★★) | |
| OTC R330G | 330 | Disease-causing (★★) | |
| OTC K221N | 221 | Disease-causing (★★) | |
| OTC E239D | 239 | Disease-causing (★★) | |
| OTC R141P | 141 | Disease-causing (★) | |
| OTC P225Q | 225 | Disease-causing (★) | |
| OTC L45R | 45 | Disease-causing (★) | |
| OTC I160F | 160 | Disease-causing (★) | |
| OTC G162R | 162 | Disease-causing (★) | |
| OTC G162V | 162 | Disease-causing (★) | |
| OTC L163Q | 163 | Disease-causing (★) | |
| OTC H168R | 168 | Disease-causing (★) | |
| OTC P169A | 169 | Disease-causing (★) | |
| OTC P169S | 169 | Disease-causing (★) | |
| OTC Q180P | 180 | Disease-causing (★) | |
| OTC Q180H | 180 | Disease-causing (★) | |
| OTC G188A | 188 | Disease-causing (★) | |
| OTC G188V | 188 | Disease-causing (★) | |
| OTC G188S | 188 | Disease-causing (★) | |
| OTC W193C | 193 | Disease-causing (★) | |
| OTC D196Y | 196 | Disease-causing (★) |
Showing 60 of 135.
Uncertain variants in Ornithine carbamoyltransferase deficiency that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| OTC M268I | 268 | Conflicting reports (★) | +7: M268K at the same position is pathogenic; seen in 8.9e-06 of gnomAD DNA copies; REVEL 0.944 | |
| OTC A140V | 140 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; A140P at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.823 | |
| OTC G162A | 162 | Conflicting reports (★) | +7: 9 other pathogenic changes within 3 positions; G162R at the same position is pathogenic; seen in 9.2e-07 of gnomAD DNA copies; REVEL 0.812 | |
| OTC G39D | 39 | Conflicting reports (★) | +7: 6 other pathogenic changes within 3 positions; G39A at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.834 | |
| OTC D126E | 126 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; D126N at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.905 | |
| OTC T343I | 343 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; T343R at the same position is pathogenic; seen in 9.2e-07 of gnomAD DNA copies; REVEL 0.780 | |
| OTC D126G | 126 | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; D126N at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.980 | |
| OTC S164P | 164 | Uncertain (★) | +7: 6 other pathogenic changes within 3 positions; S164L at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.966 | |
| OTC S203F | 203 | Conflicting reports (★) | +6: 11 other pathogenic changes within 3 positions; S203C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| OTC M206T | 206 | Conflicting reports (★) | +6: 11 other pathogenic changes within 3 positions; M206K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.85 | |
| OTC M205R | 205 | Uncertain (★) | +6: 11 other pathogenic changes within 3 positions; M205K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96 | |
| OTC P158R | 158 | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; P158L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.87 | |
| OTC D175N | 175 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; D175Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 | |
| OTC R129C | 129 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; R129H at the same position is pathogenic; REVEL 0.908 | |
| OTC S81F | 81 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; S81P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.70 | |
| OTC T242N | 242 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; T242I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.72 | |
| OTC A209G | 209 | Uncertain (★★) | +6: 10 other pathogenic changes within 3 positions; A209E at the same position is pathogenic; REVEL 0.836 |
Which prediction tools work for Ornithine carbamoyltransferase deficiency
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- CATVariant: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 82 out of 100
Diseases related to Ornithine carbamoyltransferase deficiency
- Likely inborn error of metabolism, also linked to OTC
Frequently asked questions
Which genes are linked to Ornithine carbamoyltransferase deficiency?
In CATVariant, Ornithine carbamoyltransferase deficiency is linked to 1 analyzed protein: OTC (Ornithine transcarbamylase, mitochondrial).
How many genetic variants are linked to Ornithine carbamoyltransferase deficiency?
312 variants: 135 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 141 are of uncertain significance or have conflicting reports.
Which uncertain variants in Ornithine carbamoyltransferase deficiency look disease-causing?
17 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example OTC M268I, OTC A140V, OTC G162A, OTC G39D and OTC D126E. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Ornithine carbamoyltransferase deficiency?
Among tools not trained on clinical labels, SIFT separates this disease's known disease-causing variants from harmless ones best (AUROC 0.82, based on 132 disease-causing and 8 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center